Phase III trial of docetaxel cisplatin 5‐fluorouracil induction chemotherapy for resectable oral cancer suggests favorable pathological response as a surrogate endpoint for good therapeutic outcome

oleh: Wu‐tong Ju, Ying Liu, Li‐zhen Wang, Jiang Li, Guo‐xing Ren, Jian Sun, Wen‐yong Tu, Yong‐jie Hu, Tong Ji, Wen‐jun Yang, Jun Li, Yue He, Yan‐an Wang, Chen‐ping Zhang, Lai‐ping Zhong, Zhi‐yuan Zhang